{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-3352"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-3352","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"ADVANCING CONTINUOUS MANUFACTURING: THE ROLE OF PROCESS ANALYTICAL TECHNOLOGY IN PROCESS DEVELOPMENT","abstract":"The pharmaceutical industry is actively pursuing technologies which improve manufacturing processes with the goal of producing high-quality pharmaceutical products for patients, manifesting in an industry-wide investment in continuous manufacturing (CM). Process analytical technology (PAT) has been recognized for its successful monitoring of critical quality attributes during routine production and is often cited alongside CM due to its ability to make timely, in-line measurements of intermediate materials. Various PAT tools are valuable in process development, particularly as continuous wet granulation processes are developed for use within pharmaceutical manufacturing. This work applied PAT and chemometric modeling during CM process development to enhance process understanding and reduce material consumption during model calibration. A novel strategy for analyzing granule size data was developed, resulting in a multivariate analysis of granule size distributions (GSD) via principal component analysis (PCA). The PCA of GSDs method was developed and demonstrated with a combination of synthetic and experimental data, followed by implementation alongside traditional granule size data analyses during granulation process development studies. Additionally, iterative optimization technology coupled with near-infrared spectroscopy was deployed for predicting active ingredient potency in multiple CM platforms. The reduction in material consumption during model calibration was advantageous for promoting PAT application during early pharmaceutical development. Deploying PAT tools in process development is a practical method for accelerating the adoption of novel equipment designed to accomplish CM, effectively contributing to the advancement of pharmaceutical manufacturing.","abstract_html":"The pharmaceutical industry is actively pursuing technologies which improve manufacturing processes with the goal of producing high-quality pharmaceutical products for patients, manifesting in an industry-wide investment in continuous manufacturing (CM). Process analytical technology (PAT) has been recognized for its successful monitoring of critical quality attributes during routine production and is often cited alongside CM due to its ability to make timely, in-line measurements of intermediate materials. Various PAT tools are valuable in process development, particularly as continuous wet granulation processes are developed for use within pharmaceutical manufacturing. This work applied PAT and chemometric modeling during CM process development to enhance process understanding and reduce material consumption during model calibration. A novel strategy for analyzing granule size data was developed, resulting in a multivariate analysis of granule size distributions (GSD) via principal component analysis (PCA). The PCA of GSDs method was developed and demonstrated with a combination of synthetic and experimental data, followed by implementation alongside traditional granule size data analyses during granulation process development studies. Additionally, iterative optimization technology coupled with near-infrared spectroscopy was deployed for predicting active ingredient potency in multiple CM platforms. The reduction in material consumption during model calibration was advantageous for promoting PAT application during early pharmaceutical development. Deploying PAT tools in process development is a practical method for accelerating the adoption of novel equipment designed to accomplish CM, effectively contributing to the advancement of pharmaceutical manufacturing.","abstract_has_math":false,"creators":["Henson, Samuel R."],"institution":null,"degree_name":"PhD","degree_level":"Immediate Access","degree_discipline":"Pharmaceutics","degree_department":null,"school":null,"contributors":["Carl A. Anderson","James K. Drennen","Ira Buckner","Lauren Petraglia","Patrik Johansson"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:52:32Z","subjects":["Continuous Manufacturing","Process Analytical Technology","Iterative Optimization Technology","Principal Component Analysis","Process Development","Data Science","Medicinal Chemistry and Pharmaceutics","Other Chemicals and Drugs","Other Pharmacy and Pharmaceutical Sciences","Pharmaceutics and Drug Design"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/2288","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/2288","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-3352","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Carl A. Anderson","James K. Drennen","Ira Buckner","Lauren Petraglia","Patrik Johansson"]},{"key":"dc:creator","label":"Author","values":["Henson, Samuel R."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2025-01-31T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-12-20T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pharmaceutics"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Immediate Access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Continuous Manufacturing","Process Analytical Technology","Iterative Optimization Technology","Principal Component Analysis","Process Development","Data Science","Medicinal Chemistry and Pharmaceutics","Other Chemicals and Drugs","Other Pharmacy and Pharmaceutical Sciences","Pharmaceutics and Drug Design"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/2288"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The pharmaceutical industry is actively pursuing technologies which improve manufacturing processes with the goal of producing high-quality pharmaceutical products for patients, manifesting in an industry-wide investment in continuous manufacturing (CM). Process analytical technology (PAT) has been recognized for its successful monitoring of critical quality attributes during routine production and is often cited alongside CM due to its ability to make timely, in-line measurements of intermediate materials. Various PAT tools are valuable in process development, particularly as continuous wet granulation processes are developed for use within pharmaceutical manufacturing. This work applied PAT and chemometric modeling during CM process development to enhance process understanding and reduce material consumption during model calibration. A novel strategy for analyzing granule size data was developed, resulting in a multivariate analysis of granule size distributions (GSD) via principal component analysis (PCA). The PCA of GSDs method was developed and demonstrated with a combination of synthetic and experimental data, followed by implementation alongside traditional granule size data analyses during granulation process development studies. Additionally, iterative optimization technology coupled with near-infrared spectroscopy was deployed for predicting active ingredient potency in multiple CM platforms. The reduction in material consumption during model calibration was advantageous for promoting PAT application during early pharmaceutical development. Deploying PAT tools in process development is a practical method for accelerating the adoption of novel equipment designed to accomplish CM, effectively contributing to the advancement of pharmaceutical manufacturing."]},{"key":"dc:title","label":"Title","values":["ADVANCING CONTINUOUS MANUFACTURING: THE ROLE OF PROCESS ANALYTICAL TECHNOLOGY IN PROCESS DEVELOPMENT"]}]}],"canonical_facts":{"dc:contributor":["Carl A. Anderson","James K. Drennen","Ira Buckner","Lauren Petraglia","Patrik Johansson"],"dc:creator":["Henson, Samuel R."],"dc:date.available":["2025-01-31T08:00:00Z"],"dc:date.created":["2024-12-20T08:00:00Z"],"dc:description.abstract":["The pharmaceutical industry is actively pursuing technologies which improve manufacturing processes with the goal of producing high-quality pharmaceutical products for patients, manifesting in an industry-wide investment in continuous manufacturing (CM). Process analytical technology (PAT) has been recognized for its successful monitoring of critical quality attributes during routine production and is often cited alongside CM due to its ability to make timely, in-line measurements of intermediate materials. Various PAT tools are valuable in process development, particularly as continuous wet granulation processes are developed for use within pharmaceutical manufacturing. This work applied PAT and chemometric modeling during CM process development to enhance process understanding and reduce material consumption during model calibration. A novel strategy for analyzing granule size data was developed, resulting in a multivariate analysis of granule size distributions (GSD) via principal component analysis (PCA). The PCA of GSDs method was developed and demonstrated with a combination of synthetic and experimental data, followed by implementation alongside traditional granule size data analyses during granulation process development studies. Additionally, iterative optimization technology coupled with near-infrared spectroscopy was deployed for predicting active ingredient potency in multiple CM platforms. The reduction in material consumption during model calibration was advantageous for promoting PAT application during early pharmaceutical development. Deploying PAT tools in process development is a practical method for accelerating the adoption of novel equipment designed to accomplish CM, effectively contributing to the advancement of pharmaceutical manufacturing."],"dc:identifier":["https://dsc.duq.edu/etd/2288"],"dc:language":["English"],"dc:subject":["Continuous Manufacturing","Process Analytical Technology","Iterative Optimization Technology","Principal Component Analysis","Process Development","Data Science","Medicinal Chemistry and Pharmaceutics","Other Chemicals and Drugs","Other Pharmacy and Pharmaceutical Sciences","Pharmaceutics and Drug Design"],"dc:title":["ADVANCING CONTINUOUS MANUFACTURING: THE ROLE OF PROCESS ANALYTICAL TECHNOLOGY IN PROCESS DEVELOPMENT"],"thesis:degree_discipline":["Pharmaceutics"],"thesis:degree_level":["Immediate Access"],"thesis:degree_name":["PhD"]},"updated_at":"2026-11-19T07:52:32Z"}